| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Extremely Premature | 11 | 2022 | 18 | 4.270 |
Why?
|
| Birth Weight | 11 | 2019 | 186 | 3.460 |
Why?
|
| Infant, Premature, Diseases | 6 | 2020 | 85 | 3.010 |
Why?
|
| Infant Mortality | 6 | 2022 | 59 | 2.120 |
Why?
|
| Gestational Age | 16 | 2021 | 389 | 2.000 |
Why?
|
| Infant, Newborn | 32 | 2022 | 2453 | 1.850 |
Why?
|
| Infant, Very Low Birth Weight | 6 | 2022 | 69 | 1.650 |
Why?
|
| Infant, Small for Gestational Age | 6 | 2018 | 44 | 1.550 |
Why?
|
| Neurodevelopmental Disorders | 4 | 2019 | 50 | 1.500 |
Why?
|
| Intensive Care Units, Neonatal | 5 | 2022 | 113 | 1.390 |
Why?
|
| Body Mass Index | 8 | 2019 | 866 | 1.340 |
Why?
|
| Anthropometry | 3 | 2018 | 64 | 1.340 |
Why?
|
| Pregnancy | 24 | 2022 | 2331 | 1.300 |
Why?
|
| Diabetes, Gestational | 4 | 2017 | 81 | 1.300 |
Why?
|
| Delivery, Obstetric | 2 | 2020 | 58 | 1.250 |
Why?
|
| Enterocolitis, Necrotizing | 5 | 2022 | 37 | 1.210 |
Why?
|
| DNA Copy Number Variations | 2 | 2017 | 27 | 1.170 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2017 | 27 | 1.110 |
Why?
|
| Pre-Eclampsia | 3 | 2017 | 202 | 1.100 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 378 | 1.080 |
Why?
|
| Trisomy | 3 | 2014 | 47 | 1.000 |
Why?
|
| Infant, Premature | 6 | 2019 | 284 | 1.000 |
Why?
|
| Pregnancy in Diabetics | 2 | 2016 | 70 | 0.990 |
Why?
|
| Morbidity | 3 | 2019 | 130 | 0.950 |
Why?
|
| Sepsis | 3 | 2018 | 233 | 0.940 |
Why?
|
| Hospital Mortality | 6 | 2019 | 384 | 0.940 |
Why?
|
| Chromosome Disorders | 2 | 2014 | 31 | 0.890 |
Why?
|
| Down Syndrome | 3 | 2014 | 119 | 0.880 |
Why?
|
| Convalescence | 1 | 2022 | 11 | 0.870 |
Why?
|
| Infant | 13 | 2022 | 2891 | 0.860 |
Why?
|
| Female | 45 | 2022 | 38015 | 0.860 |
Why?
|
| Pregnancy Outcome | 5 | 2021 | 157 | 0.830 |
Why?
|
| Cesarean Section | 2 | 2021 | 101 | 0.790 |
Why?
|
| Parity | 3 | 2015 | 71 | 0.770 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2018 | 38 | 0.760 |
Why?
|
| Growth Charts | 2 | 2018 | 16 | 0.750 |
Why?
|
| Cephalometry | 3 | 2019 | 19 | 0.740 |
Why?
|
| Weight Gain | 5 | 2019 | 135 | 0.710 |
Why?
|
| Twins | 1 | 2019 | 42 | 0.700 |
Why?
|
| Humans | 49 | 2022 | 68525 | 0.700 |
Why?
|
| Diseases in Twins | 1 | 2019 | 31 | 0.700 |
Why?
|
| Prune Belly Syndrome | 1 | 2017 | 5 | 0.640 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2017 | 8 | 0.630 |
Why?
|
| Male | 29 | 2020 | 37281 | 0.620 |
Why?
|
| Body Composition | 1 | 2018 | 119 | 0.620 |
Why?
|
| Ibuprofen | 1 | 2017 | 30 | 0.610 |
Why?
|
| Vitamins | 1 | 2018 | 134 | 0.610 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 208 | 0.590 |
Why?
|
| Indomethacin | 1 | 2017 | 107 | 0.590 |
Why?
|
| United States | 13 | 2022 | 7335 | 0.580 |
Why?
|
| Triglycerides | 1 | 2017 | 184 | 0.580 |
Why?
|
| Diet, Mediterranean | 2 | 2013 | 12 | 0.570 |
Why?
|
| Pregnancy, Multiple | 1 | 2016 | 32 | 0.560 |
Why?
|
| Retrospective Studies | 12 | 2022 | 7264 | 0.560 |
Why?
|
| Tetraspanins | 1 | 2015 | 2 | 0.560 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2015 | 7 | 0.560 |
Why?
|
| Premature Birth | 5 | 2021 | 148 | 0.550 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 186 | 0.550 |
Why?
|
| Urethral Stricture | 1 | 2015 | 19 | 0.550 |
Why?
|
| Head | 1 | 2016 | 59 | 0.550 |
Why?
|
| Sequence Deletion | 1 | 2015 | 89 | 0.540 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 51 | 0.540 |
Why?
|
| Cadherins | 1 | 2015 | 93 | 0.530 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 292 | 0.530 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 239 | 0.520 |
Why?
|
| Gravidity | 1 | 2014 | 11 | 0.520 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 186 | 0.510 |
Why?
|
| Pregnancy Complications | 4 | 2019 | 286 | 0.510 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 222 | 0.500 |
Why?
|
| Data Collection | 4 | 2019 | 420 | 0.490 |
Why?
|
| Risk Factors | 13 | 2019 | 5719 | 0.480 |
Why?
|
| Adult | 19 | 2021 | 21375 | 0.470 |
Why?
|
| Vitamin D | 1 | 2018 | 516 | 0.470 |
Why?
|
| Patient Compliance | 2 | 2013 | 402 | 0.460 |
Why?
|
| Body Fat Distribution | 1 | 2013 | 8 | 0.460 |
Why?
|
| Insulin | 1 | 2016 | 617 | 0.440 |
Why?
|
| Postpartum Period | 1 | 2013 | 67 | 0.440 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 529 | 0.400 |
Why?
|
| Longitudinal Studies | 6 | 2018 | 1054 | 0.400 |
Why?
|
| Feeding Behavior | 1 | 2013 | 224 | 0.390 |
Why?
|
| Obesity | 2 | 2017 | 1074 | 0.390 |
Why?
|
| Incidence | 6 | 2015 | 1582 | 0.390 |
Why?
|
| Body Weight | 1 | 2013 | 554 | 0.390 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 3256 | 0.390 |
Why?
|
| Retinopathy of Prematurity | 2 | 2022 | 34 | 0.380 |
Why?
|
| Cohort Studies | 5 | 2017 | 2356 | 0.360 |
Why?
|
| Logistic Models | 5 | 2018 | 1419 | 0.360 |
Why?
|
| Immunization | 2 | 2019 | 86 | 0.350 |
Why?
|
| Young Adult | 7 | 2019 | 5708 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2014 | 17 | 0.330 |
Why?
|
| Blood Pressure | 1 | 2015 | 1447 | 0.330 |
Why?
|
| Recurrence | 4 | 2015 | 948 | 0.330 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 2 | 2018 | 4 | 0.330 |
Why?
|
| Epidemiologic Methods | 2 | 2017 | 83 | 0.310 |
Why?
|
| Cross-Sectional Studies | 6 | 2017 | 2264 | 0.310 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2017 | 41 | 0.310 |
Why?
|
| Fetal Development | 2 | 2018 | 70 | 0.310 |
Why?
|
| Pediatric Obesity | 2 | 2019 | 91 | 0.290 |
Why?
|
| Utah | 3 | 2015 | 27 | 0.290 |
Why?
|
| Odds Ratio | 3 | 2019 | 880 | 0.290 |
Why?
|
| Fetal Growth Retardation | 2 | 2017 | 56 | 0.280 |
Why?
|
| Vaccination | 2 | 2017 | 182 | 0.280 |
Why?
|
| Absorptiometry, Photon | 2 | 2018 | 83 | 0.270 |
Why?
|
| Hospitalization | 2 | 2022 | 977 | 0.270 |
Why?
|
| Overweight | 2 | 2019 | 186 | 0.260 |
Why?
|
| Linear Models | 3 | 2017 | 521 | 0.260 |
Why?
|
| Risk | 2 | 2018 | 563 | 0.260 |
Why?
|
| Socioeconomic Factors | 3 | 2018 | 955 | 0.250 |
Why?
|
| Case-Control Studies | 3 | 2021 | 1548 | 0.250 |
Why?
|
| Genotype | 2 | 2017 | 785 | 0.250 |
Why?
|
| Phenotype | 2 | 2017 | 946 | 0.230 |
Why?
|
| Maternal Age | 3 | 2019 | 70 | 0.230 |
Why?
|
| Reference Values | 2 | 2016 | 579 | 0.230 |
Why?
|
| Trisomy 13 Syndrome | 2 | 2014 | 5 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2014 | 18 | 0.230 |
Why?
|
| Nutrition Assessment | 2 | 2013 | 43 | 0.230 |
Why?
|
| Adolescent | 6 | 2019 | 8903 | 0.220 |
Why?
|
| Child, Preschool | 4 | 2017 | 3185 | 0.220 |
Why?
|
| Energy Intake | 2 | 2013 | 123 | 0.210 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2022 | 34 | 0.210 |
Why?
|
| Databases, Factual | 2 | 2016 | 621 | 0.200 |
Why?
|
| Time Factors | 3 | 2021 | 4655 | 0.200 |
Why?
|
| Disabled Persons | 1 | 2022 | 94 | 0.200 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 46 | 0.190 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 95 | 0.190 |
Why?
|
| Length of Stay | 2 | 2022 | 780 | 0.190 |
Why?
|
| Mothers | 2 | 2019 | 172 | 0.190 |
Why?
|
| Chronic Pain | 1 | 2022 | 110 | 0.190 |
Why?
|
| Survival Rate | 3 | 2013 | 1055 | 0.190 |
Why?
|
| Puerto Rico | 1 | 2019 | 24 | 0.180 |
Why?
|
| Chorioamnionitis | 1 | 2019 | 40 | 0.180 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2077 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 2 | 2022 | 198 | 0.170 |
Why?
|
| Demography | 1 | 2020 | 279 | 0.170 |
Why?
|
| Risk Assessment | 3 | 2018 | 2004 | 0.170 |
Why?
|
| New York | 2 | 2017 | 223 | 0.170 |
Why?
|
| Prospective Studies | 3 | 2021 | 3702 | 0.170 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 91 | 0.160 |
Why?
|
| Bacterial Infections | 1 | 2019 | 163 | 0.160 |
Why?
|
| Sex Distribution | 1 | 2018 | 272 | 0.160 |
Why?
|
| Sex Factors | 2 | 2018 | 1265 | 0.160 |
Why?
|
| Preexisting Condition Coverage | 1 | 2017 | 4 | 0.150 |
Why?
|
| Body Temperature | 1 | 2018 | 116 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2018 | 175 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2015 | 15 | 0.140 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2015 | 10 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2015 | 20 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2015 | 56 | 0.140 |
Why?
|
| Organ Size | 1 | 2016 | 242 | 0.140 |
Why?
|
| Dried Blood Spot Testing | 1 | 2015 | 4 | 0.140 |
Why?
|
| Urethra | 1 | 2015 | 56 | 0.130 |
Why?
|
| Biomarkers | 2 | 2021 | 1593 | 0.130 |
Why?
|
| Prenatal Care | 1 | 2016 | 117 | 0.130 |
Why?
|
| Adipokines | 1 | 2015 | 20 | 0.130 |
Why?
|
| Registries | 2 | 2016 | 730 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 154 | 0.130 |
Why?
|
| Adiposity | 1 | 2015 | 88 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 320 | 0.120 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2014 | 6 | 0.120 |
Why?
|
| Fetal Macrosomia | 1 | 2013 | 7 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2016 | 737 | 0.120 |
Why?
|
| Base Sequence | 1 | 2015 | 1015 | 0.120 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 85 | 0.120 |
Why?
|
| Asthma | 1 | 2017 | 345 | 0.120 |
Why?
|
| Food, Organic | 1 | 2013 | 3 | 0.120 |
Why?
|
| Multiple Birth Offspring | 1 | 2013 | 1 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2013 | 42 | 0.110 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 1446 | 0.110 |
Why?
|
| Waist-Hip Ratio | 1 | 2013 | 14 | 0.110 |
Why?
|
| Gene Expression | 1 | 2015 | 770 | 0.110 |
Why?
|
| Reproduction | 1 | 2013 | 48 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 929 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 627 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2012 | 9 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2012 | 9 | 0.110 |
Why?
|
| Iowa | 1 | 2011 | 33 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2013 | 221 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2011 | 242 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2013 | 159 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2015 | 374 | 0.100 |
Why?
|
| Self Report | 1 | 2013 | 370 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1851 | 0.100 |
Why?
|
| Heart Defects, Congenital | 2 | 2013 | 596 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 536 | 0.090 |
Why?
|
| Streptococcus agalactiae | 1 | 2010 | 26 | 0.090 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1046 | 0.090 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 53 | 0.090 |
Why?
|
| Motor Activity | 1 | 2013 | 621 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2010 | 92 | 0.090 |
Why?
|
| Prevalence | 3 | 2017 | 1609 | 0.070 |
Why?
|
| Prognosis | 1 | 2011 | 2093 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 772 | 0.060 |
Why?
|
| Mass Screening | 1 | 2010 | 837 | 0.060 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 2 | 2013 | 20 | 0.060 |
Why?
|
| Tertiary Healthcare | 1 | 2022 | 6 | 0.060 |
Why?
|
| Romania | 1 | 2022 | 11 | 0.060 |
Why?
|
| Poisson Distribution | 2 | 2013 | 84 | 0.050 |
Why?
|
| Child | 3 | 2019 | 6400 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2022 | 67 | 0.050 |
Why?
|
| Parturition | 1 | 2022 | 15 | 0.050 |
Why?
|
| Africa South of the Sahara | 1 | 2021 | 25 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2022 | 50 | 0.050 |
Why?
|
| Maternal Health | 1 | 2019 | 8 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 159 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 546 | 0.040 |
Why?
|
| Medicaid | 1 | 2022 | 301 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 265 | 0.040 |
Why?
|
| Perinatal Death | 1 | 2018 | 4 | 0.040 |
Why?
|
| Hypothermia | 1 | 2018 | 37 | 0.040 |
Why?
|
| Birth Certificates | 1 | 2017 | 15 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2022 | 503 | 0.040 |
Why?
|
| Fever | 1 | 2018 | 96 | 0.040 |
Why?
|
| Patient Admission | 1 | 2018 | 99 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 498 | 0.040 |
Why?
|
| Social Environment | 1 | 2017 | 182 | 0.030 |
Why?
|
| Resistin | 1 | 2015 | 9 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 1026 | 0.030 |
Why?
|
| South Carolina | 1 | 2022 | 2750 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 294 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2018 | 1329 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2013 | 86 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1425 | 0.030 |
Why?
|
| Cause of Death | 1 | 2013 | 241 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 119 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1465 | 0.020 |
Why?
|
| Serotyping | 1 | 2010 | 16 | 0.020 |
Why?
|
| Lebanon | 1 | 2010 | 67 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2010 | 35 | 0.020 |
Why?
|
| Neonatal Screening | 1 | 2010 | 43 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2010 | 45 | 0.020 |
Why?
|
| Obstetric Labor, Premature | 1 | 2010 | 76 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 2798 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 7028 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 21119 | 0.010 |
Why?
|